ATLANTA (October 11, 2024) – Smith, Gambrell & Russell, LLP (SGR) is pleased to announce that the Firm advised the Brightly Network on the strategic sale of Bluprint Oncology, Cogency, Verascity, and Blendworks to Petauri. These Brightly Network companies are a suite of medical communications agencies that specialize in oncology, hematology, and rare diseases across medical and commercial strategy, engagement, and education.

The SGR legal team was led by Rett Peaden, Partner in the Corporate Practice in the Firm’s Atlanta office, Erin McCallum, Partner in the Corporate Practice in the Firm’s Atlanta office, Julie Sebastian, Partner in the Corporate Practice in the Firm’s Atlanta office and Harison Puder, Associate in the Corporate Practice in the Firm’s Atlanta office.

SGR’s Mergers and Acquisitions attorneys have extensive experience representing private and public companies in a wide range of transactions, including mergers, acquisitions, and divestitures, as well as equity and debt financings, leveraged buyouts, joint ventures, and going-private transactions.

About Smith Gambrell Russell
SGR is a full-service, international law firm that advises regional, national and global businesses on a wide range of legal matters. The Firm’s nearly 350 attorneys provide legal counsel in more than 50 specialized practice areas, including corporate transactions, litigation, intellectual property, aviation, banking, real estate, insurance/reinsurance, construction, employment law, international, and employee benefits and executive compensation. Founded in 1893, SGR has 14 domestic and international offices, including Atlanta; Austin; Charlotte; Chicago; Jacksonville, FL; London; Los Angeles; Miami; Munich; New York; Southampton; Springfield, IL; Tampa, FL; and Washington, D.C.